The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Plc Share News (WISE)

Share Price Information for Wise Plc (WISE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 800.50
Bid: 801.00
Ask: 802.00
Change: -6.00 (-0.74%)
Spread: 1.00 (0.125%)
Open: 805.50
High: 808.00
Low: 794.50
Prev. Close: 806.50
WISE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks rise as Asia rallies; Biffa falls on delay

Mon, 27th Jun 2022 09:09

(Alliance News) - Stock prices in London opened higher on Monday amid hopes of less aggressive monetary policy tightening by central banks, while Biffa shares fell after a delay to the publication of its annual results.

Global stock markets are recovering ground, as investors believe central banks could decide to raise interest rates by less than previously expected.

The FTSE 100 index was up 49.93 points, or 0.7%, at 7,258.74. The mid-cap FTSE 250 index was up 141.41 points, or 0.7%, at 19,265.12. The AIM All-Share index was up 6.99 points, or 0.8%, at 903.26.

The Cboe UK 100 index was up 0.6% at 723.60. The Cboe 250 was up 0.8% at 16,894.33 and the Cboe Small Companies up 0.1% at 13,508.71.

Paris and Frankfurt also were making gains. The CAC 40 stock index was up 0.9%, while the DAX 40 was up 1.2%.

In the FTSE 100, oil majors Shell and BP were up 1.8% and 1.1% respectively, tracking spot oil prices higher.

Brent oil was trading at USD113.81 a barrel Monday morning, up from USD113.44 late Friday.

Conversely, AstraZeneca was down 0.2%, even after two key breast cancer treatments were recommended for European approval.

AstraZeneca said its Lynparza treatment has been recommended for approval in the European Union by the Committee for Medicinal Products for Human Use for early breast cancer treatment, after positive phase-three results. Lynparza also demonstrated a statistically significant and clinically meaningful improvement in overall survival, reducing the risk of death by 32% versus placebo, the drugmaker said.

Separately, Astra said its Enhertu drug also has been recommended for approval in the European Union for patients with breast cancer. The CHMP based its positive opinion on results from the Destiny-Breast03 phase three trial, which were published in The New England Journal of Medicine. The trial results showed that Enhertu reduced the risk of disease progression or death by 72% compared with the trastuzumab emtansine drug.

Lynparza was co-developed by Astra with Merck & Co, while Enhertu was jointly developed with Daiichi Sankyo.

In the FTSE 250, PZ Cussons was up 1.1% after the personal care products maker said trading for the fourth quarter to May 31 continued to be in line with expectations despite a challenging trading environment.

The Carex, St Tropez and Imperial Leather products maker expects revenue for the financial year of GBP590 million, with full-year like-for-like revenue growth of 3% and fourth-quarter LFL growth of 7%. PZ Cussons recorded revenue of GBP603.3 million in financial 2021.

PZ Cussons said growth continues to be driven primarily by improvements in price mix, with limited impact on volumes. Its expectations for annual adjusted pretax profit are unchanged.

At the other end of the midcaps, Biffa was down 1.4% at 401.40 pence.

The waste management company said the release of its financial 2022 results will be delayed, as it has requested additional time to complete the audit procedures related to its landfill tax enquiry.

Biffa said the results will be released as soon as auditor Deloitte has completed its work and expects adjusted results in line with earlier trading updates. Biffa's financial year ended in March.

Earlier this month, Biffa said it had received a series of "unsolicited and indicative" proposals from private equity firm Energy Capital Partners LLC, an investor in the fields of energy transition, renewables and infrastructure. It said it was "minded to recommend" a possible offer of 445p per share in cash, valuing Biffa around GBP1.36 billion.

Elsewhere, Wise was up 0.3%, even after the money transfers provider said the UK regulator is investigating its chief executive after a tax breach.

Wise said the UK Financial Conduct Authority has opened an investigation into Co-Founder & Chief Executive Officer Kristo Kaarmann.

Wise said that UK tax collector HM Revenue & Customs in September of last year updated its published list of individuals and businesses receiving penalties for a deliberate default regarding their tax affairs. Kaarmann was included on the list and will remain so for 12 months from its publication.

Following Kaarman's inclusion on the list, the board of Wise had conducted an investigation with the help of external legal counsel and shared the findings of this with the FCA.

Wise said Kaarmann intends to cooperate fully with the FCA in its investigation.

In Asia on Monday, the Japanese Nikkei 225 index closed up 1.4%. In China, the Shanghai Composite ended up 1.8%, while the Hang Seng index in Hong Kong was 2.4% higher. The S&P/ASX 200 in Sydney closed up 1.9%.

The pound was quoted at USD1.2328 early Monday, up from USD1.2282 at the London equities close Friday.

The euro was priced at USD1.0580, up from USD1.0549. Against the yen, the dollar was quoted at JPY135.04 in London, lower against JPY135.10.

Gold stood at USD1,837.66 an ounce, higher against USD1,830.41 late Friday.

Monday's economic calendar has US durable goods orders data at 1330 BST. The week picks up pace with a US consumer confidence reading on Wednesday, eurozone unemployment data on Thursday, before inflation readings from the bloc on Friday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
29 Apr 2022 09:47

LONDON BROKER RATINGS: BofA cuts Vodafone; Jefferies cuts Brewin

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
11 Apr 2022 09:55

LONDON BROKER RATINGS: Jefferies raises John Wood; Investec cuts Metro

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
22 Mar 2022 09:45

LONDON BROKER RATINGS: Bank of America says buy Experian and Intertek

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
24 Feb 2022 21:57

TRADING UPDATES: Enwell shuts down operations; i3 ups oil production

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
20 Jan 2022 09:50

LONDON BROKER RATINGS: Liberum downgrades Antofagasta, Anglo and Rio

LONDON BROKER RATINGS: Liberum downgrades Antofagasta, Anglo and Rio

Read more
19 Jan 2022 10:36

TOP NEWS: Wise ups outlook again as volumes to trump lower take rate

TOP NEWS: Wise ups outlook again as volumes to trump lower take rate

Read more
17 Jan 2022 09:44

LONDON BROKER RATINGS: Bernstein cuts Unilever; UBS raises Antofagasta

LONDON BROKER RATINGS: Bernstein cuts Unilever; UBS raises Antofagasta

Read more
30 Dec 2021 14:16

London market cream of crop in Europe amid bumper year of IPOs

London market cream of crop in Europe amid bumper year of IPOs

Read more
17 Dec 2021 16:20

DIRECTOR DEALINGS: Watches of Switzerland CFO banks GBP5 million

DIRECTOR DEALINGS: Watches of Switzerland CFO banks GBP5 million

Read more
30 Nov 2021 17:05

LONDON MARKET CLOSE: Stocks sink on Moderna's Omicron vaccine warning

LONDON MARKET CLOSE: Stocks sink on Moderna's Omicron vaccine warning

Read more
30 Nov 2021 12:16

LONDON MARKET MIDDAY: Omicron sell-off resumes on vaccine doubts

LONDON MARKET MIDDAY: Omicron sell-off resumes on vaccine doubts

Read more
30 Nov 2021 10:40

Wise ups revenue guidance as transactions surge

(Sharecast News) - Wise upgraded its revenue outlook as the money-transfer company reported first-half profit dented by employee and flotation costs.

Read more
30 Nov 2021 09:59

Wise shares rise after revenue guidance bolstered but costs up

Wise shares rise after revenue guidance bolstered but costs up

Read more
30 Nov 2021 09:01

LONDON MARKET OPEN: Stocks resume slide as Omicron optimism flounders

LONDON MARKET OPEN: Stocks resume slide as Omicron optimism flounders

Read more
30 Nov 2021 07:56

LONDON MARKET PRE-OPEN: easyJet sees demand soften amid Omicron worry

LONDON MARKET PRE-OPEN: easyJet sees demand soften amid Omicron worry

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.